- Filed
- Nov 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 13, 2024 | 54.22M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $1.44M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $2.28M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $289K |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $311K |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $617K |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $671K |
| Current Assets | Q3 2024 · Sep 30, 2024 | $1.58M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $2.32M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $1.76M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $2.48M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 54.56M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 54.53M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $18K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$469K |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $2.01M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $2.14M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $2.29M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $2.43M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.00 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.01 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.01 |
| Net Income | Q3 2024 · Sep 30, 2023 | −$150K |
| Net Income | Q3 2024 · Sep 30, 2023 | −$512K |
| Net Income restated | Q3 2024 · Jun 30, 2023 | −$183K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$179K |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$173K |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$581K |